<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">JAMA</journal-id><journal-id journal-id-type="iso-abbrev">JAMA</journal-id><journal-id journal-id-type="pmc-domain-id">3211</journal-id><journal-id journal-id-type="pmc-domain">jamasd</journal-id><journal-title-group><journal-title>JAMA</journal-title></journal-title-group><issn pub-type="ppub">0098-7484</issn><issn pub-type="epub">1538-3598</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>JAMA Network</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10704340</article-id><article-id pub-id-type="pmcid-ver">PMC10704340.1</article-id><article-id pub-id-type="pmcaid">10704340</article-id><article-id pub-id-type="pmcaiid">10704340</article-id><article-id pub-id-type="pmid">38059899</article-id><article-id pub-id-type="doi">10.1001/jama.2023.25463</article-id><article-id pub-id-type="publisher-id">joi230152</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="category" specific-use="electronic"><subject>Research</subject></subj-group><subj-group subj-group-type="domain" specific-use="print"><subject>Research</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Investigation</subject></subj-group><subj-group subj-group-type="online-first"><subject>Online First</subject></subj-group></article-categories><title-group><article-title>Pregnancy After Breast Cancer in Young <italic toggle="yes">BRCA </italic>Carriers</article-title><subtitle>An International Hospital-Based Cohort Study</subtitle><alt-title alt-title-type="headline">Pregnancy After Breast Cancer in Young <italic toggle="yes">BRCA </italic>Carriers</alt-title><alt-title alt-title-type="running-head">Pregnancy After Breast Cancer in Young <italic toggle="yes">BRCA </italic>Carriers</alt-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Lambertini</surname><given-names initials="M">Matteo</given-names></name><degrees>MD</degrees><xref rid="joi230152aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="joi230152aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Blondeaux</surname><given-names initials="E">Eva</given-names></name><degrees>MD</degrees><xref rid="joi230152aff3" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Agostinetto</surname><given-names initials="E">Elisa</given-names></name><degrees>MD</degrees><xref rid="joi230152aff4" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hamy</surname><given-names initials="AS">Anne-Sophie</given-names></name><degrees>MD</degrees><xref rid="joi230152aff5" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kim</surname><given-names initials="HJ">Hee Jeong</given-names></name><degrees>MD</degrees><xref rid="joi230152aff6" ref-type="aff">
<sup>6</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Di Meglio</surname><given-names initials="A">Antonio</given-names></name><degrees>MD</degrees><xref rid="joi230152aff7" ref-type="aff">
<sup>7</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bernstein Molho</surname><given-names initials="R">Rinat</given-names></name><degrees>MD</degrees><xref rid="joi230152aff8" ref-type="aff">
<sup>8</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hilbers</surname><given-names initials="F">Florentine</given-names></name><degrees>PhD</degrees><xref rid="joi230152aff9" ref-type="aff">
<sup>9</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Pogoda</surname><given-names initials="K">Katarzyna</given-names></name><degrees>MD</degrees><xref rid="joi230152aff10" ref-type="aff">
<sup>10</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Carrasco</surname><given-names initials="E">Estela</given-names></name><degrees>MD</degrees><xref rid="joi230152aff11" ref-type="aff">
<sup>11</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Punie</surname><given-names initials="K">Kevin</given-names></name><degrees>MD</degrees><xref rid="joi230152aff12" ref-type="aff">
<sup>12</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bajpai</surname><given-names initials="J">Jyoti</given-names></name><degrees>MD</degrees><xref rid="joi230152aff13" ref-type="aff">
<sup>13</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ignatiadis</surname><given-names initials="M">Michail</given-names></name><degrees>MD</degrees><xref rid="joi230152aff4" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Moore</surname><given-names initials="HCF">Halle C. F.</given-names></name><degrees>MD</degrees><xref rid="joi230152aff14" ref-type="aff">
<sup>14</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Phillips</surname><given-names initials="KA">Kelly-Anne</given-names></name><degrees>MD</degrees><xref rid="joi230152aff15" ref-type="aff">
<sup>15</sup>
</xref><xref rid="joi230152aff16" ref-type="aff">
<sup>16</sup>
</xref><xref rid="joi230152aff17" ref-type="aff">
<sup>17</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Toss</surname><given-names initials="A">Angela</given-names></name><degrees>MD</degrees><xref rid="joi230152aff18" ref-type="aff">
<sup>18</sup>
</xref><xref rid="joi230152aff19" ref-type="aff">
<sup>19</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Rousset-Jablonski</surname><given-names initials="C">Christine</given-names></name><degrees>MD</degrees><xref rid="joi230152aff20" ref-type="aff">
<sup>20</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Peccatori</surname><given-names initials="FA">Fedro A.</given-names></name><degrees>MD</degrees><xref rid="joi230152aff21" ref-type="aff">
<sup>21</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Renaud</surname><given-names initials="T">Tiphaine</given-names></name><degrees>MD</degrees><xref rid="joi230152aff22" ref-type="aff">
<sup>22</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ferrari</surname><given-names initials="A">Alberta</given-names></name><degrees>MD</degrees><xref rid="joi230152aff23" ref-type="aff">
<sup>23</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Paluch-Shimon</surname><given-names initials="S">Shani</given-names></name><degrees>MD</degrees><xref rid="joi230152aff24" ref-type="aff">
<sup>24</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Fruscio</surname><given-names initials="R">Robert</given-names></name><degrees>MD</degrees><xref rid="joi230152aff25" ref-type="aff">
<sup>25</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Cui</surname><given-names initials="W">Wanda</given-names></name><degrees>MD</degrees><xref rid="joi230152aff15" ref-type="aff">
<sup>15</sup>
</xref><xref rid="joi230152aff16" ref-type="aff">
<sup>16</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wong</surname><given-names initials="SM">Stephanie M.</given-names></name><degrees>MD</degrees><xref rid="joi230152aff26" ref-type="aff">
<sup>26</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Vernieri</surname><given-names initials="C">Claudio</given-names></name><degrees>MD</degrees><xref rid="joi230152aff27" ref-type="aff">
<sup>27</sup>
</xref><xref rid="joi230152aff28" ref-type="aff">
<sup>28</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ruddy</surname><given-names initials="KJ">Kathryn J.</given-names></name><degrees>MD</degrees><xref rid="joi230152aff29" ref-type="aff">
<sup>29</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Dieci</surname><given-names initials="MV">Maria Vittoria</given-names></name><degrees>MD</degrees><xref rid="joi230152aff30" ref-type="aff">
<sup>30</sup>
</xref><xref rid="joi230152aff31" ref-type="aff">
<sup>31</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Matikas</surname><given-names initials="A">Alexios</given-names></name><degrees>MD</degrees><xref rid="joi230152aff32" ref-type="aff">
<sup>32</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Rozenblit</surname><given-names initials="M">Mariya</given-names></name><degrees>MD</degrees><xref rid="joi230152aff33" ref-type="aff">
<sup>33</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Villarreal-Garza</surname><given-names initials="C">Cynthia</given-names></name><degrees>MD</degrees><xref rid="joi230152aff34" ref-type="aff">
<sup>34</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>De Marchis</surname><given-names initials="L">Laura</given-names></name><degrees>MD</degrees><xref rid="joi230152aff35" ref-type="aff">
<sup>35</sup>
</xref><xref rid="joi230152aff36" ref-type="aff">
<sup>36</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Del Mastro</surname><given-names initials="L">Lucia</given-names></name><degrees>MD</degrees><xref rid="joi230152aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="joi230152aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Puglisi</surname><given-names initials="F">Fabio</given-names></name><degrees>MD</degrees><xref rid="joi230152aff37" ref-type="aff">
<sup>37</sup>
</xref><xref rid="joi230152aff38" ref-type="aff">
<sup>38</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Del Pilar Estevez-Diz</surname><given-names initials="M">Maria</given-names></name><degrees>MD</degrees><xref rid="joi230152aff39" ref-type="aff">
<sup>39</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Rodriguez-Wallberg</surname><given-names initials="KA">Kenny A.</given-names></name><degrees>MD</degrees><xref rid="joi230152aff40" ref-type="aff">
<sup>40</sup>
</xref><xref rid="joi230152aff41" ref-type="aff">
<sup>41</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mrinakova</surname><given-names initials="B">Bela</given-names></name><degrees>MD</degrees><xref rid="joi230152aff42" ref-type="aff">
<sup>42</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Meister</surname><given-names initials="S">Sarah</given-names></name><degrees>MD</degrees><xref rid="joi230152aff43" ref-type="aff">
<sup>43</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Livraghi</surname><given-names initials="L">Luca</given-names></name><degrees>MD</degrees><xref rid="joi230152aff44" ref-type="aff">
<sup>44</sup>
</xref><xref rid="joi230152aff45" ref-type="aff">
<sup>45</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Clatot</surname><given-names initials="F">Florian</given-names></name><degrees>MD</degrees><xref rid="joi230152aff46" ref-type="aff">
<sup>46</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yerushalmi</surname><given-names initials="R">Rinat</given-names></name><degrees>MD</degrees><xref rid="joi230152aff47" ref-type="aff">
<sup>47</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>De Angelis</surname><given-names initials="C">Carmine</given-names></name><degrees>MD</degrees><xref rid="joi230152aff48" ref-type="aff">
<sup>48</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>S&#225;nchez-Bayona</surname><given-names initials="R">Rodrigo</given-names></name><degrees>MD</degrees><xref rid="joi230152aff49" ref-type="aff">
<sup>49</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Meattini</surname><given-names initials="I">Icro</given-names></name><degrees>MD</degrees><xref rid="joi230152aff50" ref-type="aff">
<sup>50</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Cichowska-Cwali&#324;ska</surname><given-names initials="N">Natalia</given-names></name><degrees>MD</degrees><xref rid="joi230152aff51" ref-type="aff">
<sup>51</sup>
</xref><xref rid="joi230152aff52" ref-type="aff">
<sup>52</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Berli&#232;re</surname><given-names initials="M">Martine</given-names></name><degrees>MD</degrees><xref rid="joi230152aff53" ref-type="aff">
<sup>53</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Salama</surname><given-names initials="M">Mahmoud</given-names></name><degrees>MD</degrees><xref rid="joi230152aff54" ref-type="aff">
<sup>54</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>De Giorgi</surname><given-names initials="U">Ugo</given-names></name><degrees>MD</degrees><xref rid="joi230152aff55" ref-type="aff">
<sup>55</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sonnenblick</surname><given-names initials="A">Amir</given-names></name><degrees>MD</degrees><xref rid="joi230152aff56" ref-type="aff">
<sup>56</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chiodi</surname><given-names initials="C">Camila</given-names></name><degrees>MD</degrees><xref rid="joi230152aff7" ref-type="aff">
<sup>7</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lee</surname><given-names initials="YJ">Young-Jin</given-names></name><degrees>MD</degrees><xref rid="joi230152aff6" ref-type="aff">
<sup>6</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Maria</surname><given-names initials="C">Camille</given-names></name><degrees>MD</degrees><xref rid="joi230152aff5" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Azim</surname><given-names initials="HA">Hatem A.</given-names><suffix>Jr</suffix></name><degrees>MD</degrees><xref rid="joi230152aff34" ref-type="aff">
<sup>34</sup>
</xref><xref rid="joi230152aff57" ref-type="aff">
<sup>57</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Boni</surname><given-names initials="L">Luca</given-names></name><degrees>MD</degrees><xref rid="joi230152aff3" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Partridge</surname><given-names initials="AH">Ann H.</given-names></name><degrees>MD</degrees><xref rid="joi230152aff58" ref-type="aff">
<sup>58</sup>
</xref></contrib><on-behalf-of>for the BRCA BCY Collaboration</on-behalf-of></contrib-group><aff id="joi230152aff1"><label>1</label>Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy</aff><aff id="joi230152aff2"><label>2</label>Department of Medical Oncology, U. O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy</aff><aff id="joi230152aff3"><label>3</label>U. O. Epidemiologia Clinica, IRCCS Ospedale Policlinico San Martino, Genova, Italy</aff><aff id="joi230152aff4"><label>4</label>Breast Medical Oncology Clinic, Institut Jules Bordet, Universit&#233; Libre de Bruxelles (ULB), H&#244;pital Universitaire de Bruxelles (HUB), Brussels, Belgium</aff><aff id="joi230152aff5"><label>5</label>Department of Medical Oncology, Universite Paris Cit&#233;, Institut Curie, Paris, France</aff><aff id="joi230152aff6"><label>6</label>Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea</aff><aff id="joi230152aff7"><label>7</label>Cancer Survivorship Program&#8211;Molecular Predicitors and New Targets in Oncology, INSERM Unit 981, Gustave Roussy, Villejuif, France</aff><aff id="joi230152aff8"><label>8</label>Susanne Levy Gertner Oncogenetics Unit, Danek Gertner Institute of Human Genetics, Chaim Sheba Medical Center Affiliated to Tel Aviv University, Tel Hashomer, Israel</aff><aff id="joi230152aff9"><label>9</label>Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands</aff><aff id="joi230152aff10"><label>10</label>Department of Breast Cancer and Reconstructive Surgery, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland</aff><aff id="joi230152aff11"><label>11</label>Hereditary Cancer Genetics Unit, Medical Oncology Department, Vall d&#180;Hebron University Hospital, Vall d&#180;Hebron Institute of Oncology, Barcelona, Spain</aff><aff id="joi230152aff12"><label>12</label>Department of General Medical Oncology and Multidisciplinary Breast Center, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium</aff><aff id="joi230152aff13"><label>13</label>Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India</aff><aff id="joi230152aff14"><label>14</label>Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio</aff><aff id="joi230152aff15"><label>15</label>Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia</aff><aff id="joi230152aff16"><label>16</label>Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia</aff><aff id="joi230152aff17"><label>17</label>Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia</aff><aff id="joi230152aff18"><label>18</label>Department of Oncology and Haematology, Azienda Ospedaliero&#8211;Universitaria di Modena, Modena, Italy</aff><aff id="joi230152aff19"><label>19</label>Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy</aff><aff id="joi230152aff20"><label>20</label>Department of Surgery, Leon Berard Cancer Center, Lyon, France</aff><aff id="joi230152aff21"><label>21</label>Gynecologic Oncology Department, European Institute of Oncology (IRCCS), Milan, Italy</aff><aff id="joi230152aff22"><label>22</label>Cancer Genetics Unit, Bergonie Institute, Bordeaux, France</aff><aff id="joi230152aff23"><label>23</label>Hereditary Breast and Ovarian Cancer Unit and General Surgery 3&#8211;Senology, Surgical Department, Fondazione IRCCS Policlinico San Matteo, and University of Pavia, Pavia, Italy</aff><aff id="joi230152aff24"><label>24</label>Breast Oncology Unit, Sharett Institute of Oncology, Hadassah University Hospital, and Faculty of Medicine, Hebrew University, Jerusalem, Israel</aff><aff id="joi230152aff25"><label>25</label>UO Gynecology, Department of Medicine and Surgery, University of Milan&#8211;Bicocca, IRCCS San Gerardo dei Tintori, Monza, Italy</aff><aff id="joi230152aff26"><label>26</label>Stroll Cancer Prevention Centre, Jewish General Hospital, and McGill University Medical School, Montreal, Quebec, Canada</aff><aff id="joi230152aff27"><label>27</label>Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy</aff><aff id="joi230152aff28"><label>28</label>IFOM ETS, AIRC Institute of Molecular Oncology, Milan, Italy</aff><aff id="joi230152aff29"><label>29</label>Department of Oncology, Mayo Clinic College of Medicine, Rochester, Minnesota</aff><aff id="joi230152aff30"><label>30</label>Dipartimento di Scienze Chirurgiche, Oncologiche, e Gastroenterologiche, Universit&#224; di Padova, Padova, Italy</aff><aff id="joi230152aff31"><label>31</label>Oncologia 2, Istituto Oncologico Veneto IOV-IRCCS, Padova, Italy</aff><aff id="joi230152aff32"><label>32</label>Department of Oncology/Pathology, Karolinska Institute, and Breast Center, Karolinska University Hospital, Stockholm, Sweden</aff><aff id="joi230152aff33"><label>33</label>Department of Medical Oncology, Smilow Cancer Hospital at Yale New Haven, New Haven, Connecticut</aff><aff id="joi230152aff34"><label>34</label>Breast Cancer Center, Hospital Zambrano Hellion&#8211;TecSalud, Tecnologico de Monterrey, Monterrey, Mexico</aff><aff id="joi230152aff35"><label>35</label>Department of Radiological, Oncological, and Pathological Sciences, Sapienza University of Rome, Rome, Italy</aff><aff id="joi230152aff36"><label>36</label>Division of Oncology, Department of Hematology, Oncology, and Dermatology, Umberto 1 University Hospital, Rome, Italy</aff><aff id="joi230152aff37"><label>37</label>Department of Medical Oncology, Centro di Riferimento Oncologico di Avano (CRO) IRCCS, Aviano, Italy</aff><aff id="joi230152aff38"><label>38</label>Department of Medicine, University of Udine, Udine, Italy</aff><aff id="joi230152aff39"><label>39</label>Department of Radiology and Oncology, Instituto do C&#226;ncer do Estado de S&#227;o Paulo, Faculdade de Medicina da Universidade de S&#227;o Paulo, S&#227;o Paulo, Brazil</aff><aff id="joi230152aff40"><label>40</label>Department of Oncology-Pathology, Laboratory of Translational Fertility Preservation, Karolinska Institute, Stockholm, Sweden</aff><aff id="joi230152aff41"><label>41</label>Department of Reproductive Medicine, Karolinska University Hospital, Stockholm, Sweden</aff><aff id="joi230152aff42"><label>42</label>First Department of Oncology, Comenius University and St Elisabeth Cancer Institute, Bratislava, Slovakia</aff><aff id="joi230152aff43"><label>43</label>Department of Obstetrics and Gynecology, Ludwig Maximilian University (LMU) Hospital, LMU Munich, Germany</aff><aff id="joi230152aff44"><label>44</label>Department of Medical Oncology, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy</aff><aff id="joi230152aff45"><label>45</label>Department of Medical Oncology, Hospital of Prato, Azienda USL Toscana Centro, Italy</aff><aff id="joi230152aff46"><label>46</label>Department of Medical Oncology, Centre Henri Becquerel, Rouen, France</aff><aff id="joi230152aff47"><label>47</label>Department of Medical Oncology, Davidoff Center, Rabin Medical Center, Petah Tikva, Tel Aviv University, Tel Aviv, Israel</aff><aff id="joi230152aff48"><label>48</label>Department of Medical Oncology, University of Naples Federico II, Napoli, Italy</aff><aff id="joi230152aff49"><label>49</label>Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain</aff><aff id="joi230152aff50"><label>50</label>Department of Experimental and Clinical Biomedical Sciences M. Serio, University of Florence, and Radiation Oncology Unit, Oncology Department, Florence University Hospital, Florence, Italy</aff><aff id="joi230152aff51"><label>51</label>Department of Oncology and Radiotherapy, Medical University of Gda&#324;sk, Gda&#324;sk, Poland</aff><aff id="joi230152aff52"><label>52</label>Early Phase Clinical Trials Centre, Medical University of Gda&#324;sk, Gda&#324;sk, Poland</aff><aff id="joi230152aff53"><label>53</label>Department of Medical Oncology and Breast Surgery, Cliniques Universitaires Saint Luc, Universit&#233; Catholique de Louvain (UCL), Brussels, Belgium</aff><aff id="joi230152aff54"><label>54</label>Oncofertility Consortium and Department of Obstetrics, Gynecology, and Reproductive Biology, Michigan State University, East Lansing</aff><aff id="joi230152aff55"><label>55</label>Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori, Meldola, Italy</aff><aff id="joi230152aff56"><label>56</label>Oncology Division, Tel Aviv Sourasky Medical Center, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel</aff><aff id="joi230152aff57"><label>57</label>Cairo Oncology Center, Cairo, Egypt</aff><aff id="joi230152aff58"><label>58</label>Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts</aff><author-notes><title>Article Information</title><corresp id="joi230152cor1"><bold>Corresponding Author:</bold> Matteo Lambertini, MD, Department of Medical Oncology, U. O. Clinica di Oncologia Medica, University of Genova&#8211;IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi 10, 16132 Genova, Italy (<email xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="matteo.lambertini@unige.it">matteo.lambertini@unige.it</email>).</corresp><p><bold>Accepted for Publication:</bold> November 17, 2023.</p><p content-type="published-online"><bold>Published Online:</bold> December 7, 2023. doi:<uri content-type="doi">10.1001/jama.2023.25463</uri></p><p content-type="author-contributions"><bold>Author Contributions:</bold> Drs Lambertini, Blondeaux, and Partridge had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Drs Lambertini and Blondeaux contributed equally to this work.</p><p><italic toggle="yes">Concept and design:</italic> Lambertini, Blondeaux.</p><p><italic toggle="yes">Acquisition, analysis, or interpretation of data:</italic> Lambertini, Blondeaux, Agostinetto, Hamy, Kim, Di Meglio, Bernstein Molho, Hilbers, Pogoda, Carrasco, Punie, Bajpai, Ignatiadis, Moore, Phillips, Toss, Rousset-Jablonski, Peccatori, Renaud, Ferrari, Paluch-Shimon, Fruscio, Cui, Wong, Vernieri, Ruddy, Dieci, Matikas, Rozenblit, Villarreal-Garza, De Marchis, Del Mastro, Puglisi, Del Pilar Estevez-Diz, Rodriguez-Wallberg, Mrinakova, Meister, Livraghi, Clatot, Yerushalmi, De Angelis, S&#225;nchez-Bayona, Meattini, Cichowska-Cwali&#324;ska, Berli&#232;re, Salama, De Giorgi, Sonnenblick, Chiodi, Lee, Maria, Azim, Boni, Partridge.</p><p><italic toggle="yes">Drafting of the manuscript:</italic> Lambertini, Blondeaux, Partridge.</p><p><italic toggle="yes">Critical review of the manuscript for important intellectual content:</italic> Agostinetto, Hamy, Kim, Di Meglio, Bernstein Molho, Hilbers, Pogoda, Carrasco, Punie, Bajpai, Ignatiadis, Moore, Phillips, Toss, Rousset-Jablonski, Peccatori, Renaud, Ferrari, Paluch-Shimon, Fruscio, Cui, Wong, Vernieri, Ruddy, Dieci, Matikas, Rozenblit, Villarreal-Garza, De Marchis, Del Mastro, Puglisi, Del Pilar Estevez-Diz, Rodriguez-Wallberg, Mrinakova, Meister, Livraghi, Clatot, Yerushalmi, De Angelis, S&#225;nchez-Bayona, Meattini, Cichowska-Cwali&#324;ska, Berli&#232;re, Salama, De Giorgi, Sonnenblick, Chiodi, Lee, Maria, Azim, Boni.</p><p><italic toggle="yes">Statistical analysis:</italic> Blondeaux, Boni.</p><p><italic toggle="yes">Obtained funding:</italic> Lambertini, Phillips.</p><p><italic toggle="yes">Administrative, technical, or material support:</italic> Lambertini, Agostinetto, Hamy, Kim, Di Meglio, Bernstein Molho, Hilbers, Pogoda, Carrasco, Punie, Bajpai, Moore, Phillips, Toss, Rousset-Jablonski, Peccatori, Renaud, Ferrari, Paluch-Shimon, Fruscio, Cui, Wong, Vernieri, Ruddy, Dieci, Matikas, Rozenblit, Villarreal-Garza, De Marchis, Del Mastro, Puglisi, Del Pilar Estevez-Diz, Rodriguez-Wallberg, Mrinakova, Meister, Livraghi, Clatot, Yerushalmi, De Angelis, S&#225;nchez-Bayona, Meattini, Cichowska-Cwali&#324;ska, Berli&#232;re, Salama, De Giorgi, Sonnenblick, Chiodi, Lee, Maria.</p><p><italic toggle="yes">Supervision:</italic> Azim, Boni, Partridge.</p><p content-type="COI-statement"><bold>Conflict of Interest Disclosures:</bold> Dr Lambertini reported having an advisory role for Roche, Lilly, Novartis, AstraZeneca, Pfizer, Seagen, Gilead, MSD, and Exact Sciences; receiving speaker honoraria from Roche, Lilly, Novartis, Pfizer, Sandoz, Libbs, Daiichi Sankyo, Takeda, Knight, Ipsen, and AstraZeneca; receiving travel grants from Gilead and Daiichi Sankyo; receiving research funding (to his institution) from Gilead; and having nonfinancial interests as the chair of the European Society for Medical Oncology (ESMO) Young Oncologists Committee (YOC) and as a member of the national council of the Italian Association of Medical Oncology. Dr Blondeaux reported receiving research funding (to her institution) from Gilead. Dr Agostinetto reported receiving speaker honoraria from Eli Lilly, Sandoz, AstraZeneca; research funding (to her institution) from Gilead; and meeting/travel grants from Novartis, Roche, Eli Lilly, Genetic, Istituto Gentili, Daiichi Sankyo, AstraZeneca. Dr Pogoda reported receiving honoraria for consultations/lectures/training/clinical trials and payment of conferences fees from AstraZeneca, Gilead, Roche, Novartis, Eli Lilly, Pfizer, MSD, Teva, Egis, and Vipharm. Dr Punie reported receiving research grants (to his institution) from MSD and Sanofi; speaker fees and honoraria for consultancy and advisory board functions from AstraZeneca, Eli Lilly, Exact Sciences, Focus Patient, Gilead, Menarini, MSD, Novartis, Pfizer, Roche, and Seagen; speaker fees and honoraria for consultancy and advisory board functions (to his institution) from AstraZeneca, Eli Lilly, Exact Sciences, Gilead, MSD, Novartis, Pfizer, Roche, and Seagen; stock options from Need Inc; and travel grants from AstraZeneca, Novartis, Pfizer, PharmaMar, and Roche. Dr Bajpai reported receiving research grants (to his institution) from Eli Lilly, Novartis, Roche, AstraZeneca, Paxman Coolers, Samsung Bioepis, and Sun Pharma; conducting nonremunerated advisory board activities for Novartis; and having leadership roles with the Immuno-Oncology Society of India, the Indian Society of Medical and Paediatric Oncology, the Teenage and Young Cancer Association, ESMO, and the Society for Immunotherapy of Cancer. Dr Ignatiadis reported receiving honoraria from Novartis and Seattle Genetics; research grants (to his institution) from Pfizer, Roche, Inivata Inc, Natera Inc, and Gilead; and meeting/travel grants from Roche, AstraZeneca, and Gilead. Dr Moore reported receiving consulting fees from Myovant and research support (to her institution) from Daiichi Sankyo, AstraZeneca, Roche/Genentech, Sermonix, and Seattle Genetics. Dr Phillips reported having an unpaid advisory role for AstraZeneca and receiving research funding (to her institution) from AstraZeneca. Dr Toss reported having an advisory role for Lilly, Novartis, AstraZeneca, Pfizer, Seagen, Gilead, and MSD; receiving speaker honoraria from Lilly, Novartis, and Pfizer; and receiving travel grants from Gilead and Daiichi Sankyo. Dr Rousset-Jablonski reported having an advisory role for Bristol Myers Squibb, Roche, and Theramex; receiving speaker honoraria (to her institution) from Novartis, Organon, and Theramex; and receiving research funding (to her institution) from Bayer Healthcare. Dr Cui reported receiving honoraria from Pfizer, Merck, Eisai, and AstraZeneca. Dr Vernieri reported having an advisory role for Novartis, Eli Lilly, Daiichi Sankyo, and Pfizer; consultancy for Eli Lilly; receiving research grants (to his institution) from Roche; and receiving honoraria as a speaker from Novartis, Eli Lilly, Istituto Gentili, and Accedemia di Medicina. Dr Matikas reported consultancy for Veracyte (no compensation); receiving speaker honoraria from Roche and Seagen (to his institution); and receiving research funding (to his institution) from AstraZeneca, Novartis, and MSD. Dr Del Mastro reported receiving grants from Eli Lilly, Novartis, Roche, Daiichi Sankyo, Seagen, AstraZeneca, Gilead, and Pierre Fabre; receiving consulting fees from Eli Lilly, Gilead, and Daiichi Sankyo; receiving speaker honoraria from Roche, Novartis, Pfizer, Eli Lilly, AstraZeneca, MSD, Seagen, Gilead, Pierre Fabre, Eisai, Exact Sciences, Ipsen, GSK, and Agendia-Stemline; receiving travel grants from Roche, Pfizer, Eisai, Daiichi Sankyo, and AstraZeneca; and having an advisory role for Novartis, Roche, Eli Lilly, Pfizer, Daiichi Sakyo, Exact Sciences, Gilead, Pierre Fabre, Eisai, AstraZeneca, Agendia, GSK, and Seagen. Dr Puglisi reported having an advisory role for and receiving speaker honoraria, travel grants, and research grants from Amgen, AstraZeneca, Daichii Sankyo, Celgene, Eisai, Eli Lilly, Exact Sciences, Gilead, Ipsen, Menarini, MSD, Novartis, Pierre Fabre, Pfizer, Roche, Seagen, Takeda, and Viatris. Dr Rodriguez-Wallberg reported receiving research grants from Novo Nordisk, Merck, and Ferring Pharmaceuticals (to her institution); receiving consulting fees from the Swedish Ministry of Health and Welfare as an expert in assisted reproduction and fertility preservation; and receiving speaker honoraria from Ferring Pharmaceuticals, Roche, Pfizer, Organon, and Merck. Dr Clatot reported having received speaker honoraria from BMS, Merck Serono, MSD, AstraZeneca, Novartis, Gilead, and Daiichi Sankyo and travel grants from Pfizer, Merck Serono, Nutricia, and Novartis. Dr Yerushalmi reported consulting for Roche, Pfizer, Novartis, Rhenium, Eli Lilly, Gilead, and Stemline; receiving research grants from Roche; and receiving speaker honoraria from Roche, Novartis, Medison, MSD, Astra-Zeneca, Eli Lilly, and Stemline. Dr De Angelis reported having an advisory role for Roche, Lilly, Novartis, AstraZeneca, Pfizer, Seagen, Daiichi Sankyo, Gilead, and GSK; receiving speaker honoraria from Roche, Lilly, Novartis, Pfizer, Seagen, GSK, Gilead, and Daiichi Sankyo; receiving travel grants from Gilead; and receiving research support (to her institution) from Novartis, Gilead, and Daiichi Sankyo. Dr S&#225;nchez-Bayona reported receiving travel grants from Pfizer, Gilead, AstraZeneca, and Novartis; receiving honoraria for speaker or advisory board participation from Novartis, Lilly, AstraZeneca, Daiichi Sankyo, Gilead, Roche, GlaxoSmithKline, Clovis Oncology, Seagen, and Accord; and having nonfinancial interests as a member of the ESMO YOC and scientific secretary of the Spanish Society of Medical Oncology. Dr Meattini reported having an advisory role for Eli Lilly, Novartis, Pfizer, Seagen, Gilead, Accuray, AstraZeneca, and Daiichi Sankyo. Dr Azim reported being an employee of Emergence Therapeutics. No other disclosures were reported.</p><p content-type="funding-statement"><bold>Funding/Support:</bold> The study was partly supported by the Italian Association for Cancer Research (AIRC grant MFAG 2020 ID 24698), and the 2022 Gilead Research Scholars Program in Solid Tumors. Dr Lambertini received support from the European Society for Medical Oncology (ESMO) for a translational research fellowship at the Institut Jules Bordet in Brussels, Belgium, at the time this study was initiated. Dr Kim receives support from the Korea Health Technology R&amp;D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health and Welfare, Republic of Korea (grant HC20C0135). Dr Phillips is a Australian National Health and Medical Research Council leadership fellow. Data collection for most Australian participants was through the kConFab Follow-Up Study with support from Cancer Australia and the National Breast Cancer Foundation (PdCCRS 1100868), Cancer Australia (809195), the Australian National Breast Cancer Foundation (IF 17), the Australian National Health and Medical Research Council (454508, 288704, and 145684), the US National Institutes of Health (1RO1CA159868), the Queensland Cancer Fund, the Cancer Councils of New South Wales, Victoria, Tasmania, and South Australia, and the Cancer Foundation of Western Australia. Dr Partridge receives support from the Breast Cancer Research Foundation and Susan G. Komen.</p><p><bold>Role of the Funder/Sponsor:</bold> The study supporters had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication.</p><p><bold>Group Information:</bold> The BRCA BCY Collaboration Investigators are listed in <xref rid="note-JOI230152-1-s" ref-type="supplementary-material">Supplement 3</xref>.</p><p content-type="data-sharing-statement"><bold>Data Sharing Statement:</bold> See <xref rid="note-JOI230152-1-s" ref-type="supplementary-material">Supplement 4</xref>.</p><p><bold>Additional Contributions:</bold> Dr Phillips acknowledges Heather Thorne, PhD, (Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia), for data collection (compensated by institutional salary), all of the kConFab research nurses and staff, the heads and staff of the Family Cancer Clinics for their contributions to this resource, and the families who contribute to kConFab.</p></author-notes><pub-date pub-type="epub" iso-8601-date="2023-12-07T08:15"><day>7</day><month>12</month><year>2023</year></pub-date><pub-date pub-type="ppub"><day>2</day><month>1</month><year>2024</year></pub-date><volume>331</volume><issue>1</issue><issue-id pub-id-type="pmc-issue-id">450617</issue-id><fpage>49</fpage><lpage>59</lpage><history><date date-type="received"><day>29</day><month>10</month><year>2023</year></date><date date-type="accepted"><day>17</day><month>11</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>07</day><month>06</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>07</day><month>06</month><year>2024</year></date></event><event event-type="pmc-released-under-embargo"><date><day>04</day><month>01</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-06-07 00:25:31.797"><day>07</day><month>06</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>Copyright 2023 American Medical Association. All Rights Reserved.</copyright-statement></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="jama-e2325463.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf-version" xlink:href="jama-e2325463.pdf">jama-e2325463.pdf</self-uri><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="silverchair" xlink:href="https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.25463"/><related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="companion" xml:lang="en" xlink:title="research-article" journal-id="JAMA Oncol" journal-id-type="nlm-ta" ext-link-type="pmc" xlink:href="PMC5824205"><article-title>Association of the Timing of Pregnancy With Survival in Women With Breast Cancer</article-title><volume>3</volume><issue>5</issue><date><day>9</day><month>3</month><year>2017</year></date><fpage>659</fpage><lpage>665</lpage><source>JAMA Oncology</source><pub-id pub-id-type="doi">10.1001/jamaoncol.2017.0248</pub-id><pub-id pub-id-type="pmcid">PMC5824205</pub-id><pub-id pub-id-type="pmid">28278319</pub-id></related-article><related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="companion" xml:lang="en" journal-id="JAMA Oncol" journal-id-type="nlm-ta" ext-link-type="pubmed" xlink:href="26247818"><article-title>Breast Cancer Diagnosed During Pregnancy: Adapting Recent Advances in Breast Cancer Care for Pregnant Patients.</article-title><volume>1</volume><issue>8</issue><date><month>11</month><year>2015</year></date><fpage>1145</fpage><lpage>1153</lpage><source>JAMA Oncol</source><pub-id pub-id-type="doi">10.1001/jamaoncol.2015.2413</pub-id><pub-id pub-id-type="pmid">26247818</pub-id></related-article><abstract abstract-type="key-points"><title>Key Points</title><sec id="ab-joi230152-1"><title>Question</title><p>Among women carrying germline <italic toggle="yes">BRCA</italic> pathogenic variants, is pregnancy after breast cancer associated with adverse maternal or fetal outcomes?</p></sec><sec id="ab-joi230152-2"><title>Findings</title><p>This international, hospital-based, retrospective cohort study including 4732 <italic toggle="yes">BRCA</italic> carriers showed that 1 in 5 patients conceived within 10 years after breast cancer diagnosis. Pregnancy following breast cancer in <italic toggle="yes">BRCA </italic>carriers was not associated with adverse maternal prognosis or fetal outcomes.</p></sec><sec id="ab-joi230152-3"><title>Meaning</title><p>The cumulative incidence of pregnancy after breast cancer and disease-free survival in this large international cohort of young <italic toggle="yes">BRCA</italic> carriers may inform care for affected patients.</p></sec></abstract><abstract><sec id="ab-joi230152-4"><title>Importance</title><p>Young women with breast cancer who have germline pathogenic variants in <italic toggle="yes">BRCA1</italic> or <italic toggle="yes">BRCA2</italic> face unique challenges regarding fertility. Previous studies demonstrating the feasibility and safety of pregnancy in breast cancer survivors included limited data regarding <italic toggle="yes">BRCA</italic> carriers.</p></sec><sec id="ab-joi230152-5"><title>Objective</title><p>To investigate cumulative incidence of pregnancy and disease-free survival in young women who are <italic toggle="yes">BRCA</italic> carriers.</p></sec><sec id="ab-joi230152-6"><title>Design, Setting, and Participants</title><p>International, multicenter, hospital-based, retrospective cohort study conducted at 78 participating centers worldwide. The study included female participants diagnosed with invasive breast cancer at age 40 years or younger between January 2000 and December 2020 carrying germline pathogenic variants in <italic toggle="yes">BRCA1</italic> and/or <italic toggle="yes">BRCA2</italic>. Last delivery was October 7, 2022; last follow-up was February 20, 2023.</p></sec><sec id="ab-joi230152-7"><title>Exposure</title><p>Pregnancy after breast cancer.</p></sec><sec id="ab-joi230152-8"><title>Main Outcomes and Measures</title><p>Primary end points were cumulative incidence of pregnancy after breast cancer and disease-free survival. Secondary end points were breast cancer&#8211;specific survival, overall survival, pregnancy, and fetal and obstetric outcomes.</p></sec><sec id="ab-joi230152-9"><title>Results</title><p>Of 4732 <italic toggle="yes">BRCA</italic> carriers included, 659 had at least 1 pregnancy after breast cancer and 4073 did not. Median age at diagnosis in the overall cohort was 35 years (IQR, 31-38 years). Cumulative incidence of pregnancy at 10 years was 22% (95% CI, 21%-24%), with a median time from breast cancer diagnosis to conception of 3.5 years (IQR, 2.2-5.3 years). Among the 659 patients who had a pregnancy, 45 (6.9%) and 63 (9.7%) had an induced abortion or a miscarriage, respectively. Of the 517 patients (79.7%) with a completed pregnancy, 406 (91.0%) delivered at term (&#8805;37 weeks) and 54 (10.4%) had twins. Among the 470 infants born with known information on pregnancy complications, 4 (0.9%) had documented congenital anomalies. Median follow-up was 7.8 years (IQR, 4.5-12.6 years). No significant difference in disease-free survival was observed between patients with or without a pregnancy after breast cancer (adjusted hazard ratio, 0.99; 95% CI, 0.81-1.20). Patients who had a pregnancy had significantly better breast cancer&#8211;specific survival and overall survival.</p></sec><sec id="ab-joi230152-10"><title>Conclusions and Relevance</title><p>In this global study, 1 in 5 young <italic toggle="yes">BRCA</italic> carriers conceived within 10 years after breast cancer diagnosis. Pregnancy following breast cancer in <italic toggle="yes">BRCA</italic> carriers was not associated with decreased disease-free survival.</p></sec><sec id="ab-joi230152-11"><title>Trial Registration</title><p>ClinicalTrials.gov Identifier: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.clinicaltrials.gov/study/NCT03673306" ext-link-type="uri">NCT03673306</ext-link></p></sec></abstract><abstract abstract-type="teaser" specific-use="electronic"><p>This retrospective cohort study assesses the cumulative incidence of pregnancy after cancer and disease-free survival in <italic toggle="yes">BRCA</italic> carriers diagnosed with invasive breast cancer at age 40 years or younger.</p></abstract><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>